Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
Dietary n-3 fatty acids and therapy for rheumatoid arthritis
1997
EGFR Antagonists in Cancer Treatment
2008 Standout
Eicosanoids in sickle cell disease: Potential relevance of neutrophil leukotriene B4 to disease pathophysiology
2002
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
The tor pathway: a target for cancer therapy
2004 Standout
Clinical translation of angiogenesis inhibitors
2002 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Acute Myeloid Leukemia in the Elderly
2008
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study
2005
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Angiogenesis and antiangiogenic therapy in hematologic malignancies
2006
Corynebacterium CDC Group JK (Corynebacterium jeikeium) Sepsis in Haematological Patients: A Report of Three Cases and a Systematic Literature Review
1995
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Corynebacterium jeikeium bacteremia at a tertiary care center
1991
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
The biology of VEGF and its receptors
2003 Standout
Nonresolving Inflammation
2010 Standout
Stimulus-Secretion Coupling in Vascular Endothelial Cells
1990
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
2003 StandoutNobel
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Angiogenesis-dependent diseases
2001
Antifungal prophylaxis for severely neutropenic chemotherapy recipients
2002
Platelets and the immune continuum
2011 Standout
Cefepime as Empirical Monotherapy in Febrile Patients with Hematological Malignancies and Neutropenia: A Randomized, Single-Center Phase II Trial
1999
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Sickle-cell disease
2010 Standout
The evaluation and management of platelet refractoriness and alloimmunization
2000
Lipoxin biosynthesis and its impact in inflammatory and vascular events
1994
The role of VEGF in normal and neoplastic hematopoiesis
2002
Capturing complex 3D tissue physiology in vitro
2006 Standout
Neutrophils, from Marrow to Microbes
2010 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
2008 Standout
A papular eruption secondary to infection with Corynebacterium jeikeiwn, with histopathological features mimicking botryomycosis
2006
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
Randomized Placebo‐Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy
1999
A New Ciprofloxacin Stepdown Program in the Treatment of High‐Risk Febrile Neutropenia: A Clinical and Economic Analysis
2000
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
1997 Nature
Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins αvβ3 and α6β1 in Human Umbilical Vein Endothelial Cells
2002 Standout
High mobility group 1 B‐box mediates activation of human endothelium
2003
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Tumor Angiogenesis
2008 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Signalling through the leukotriene B4 receptor involves both αi and α16, but not αq or α11 G-protein subunits
1998
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
2004 Standout
Angiogenesis Research: Guidelines for Translation to Clinical Application
2001
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Coryneform bacteria in infectious diseases: clinical and laboratory aspects
1990
Platelet-activating factor.
1990 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Increased Acute Inflammation, Leukotriene B4-Induced Chemotaxis, and Signaling in Mice Deficient for G Protein-Coupled Receptor Kinase 6
2003 StandoutNobel
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Functions of Ceramide in Coordinating Cellular Responses to Stress
1996 StandoutScience
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
2002
Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia
2005
Aspergillus fumigatusand Aspergillosis
1999 Standout
Clinical microbiology of coryneform bacteria
1997 Standout
Practical modalities for prevention of fungal infections in cancer patients
1997
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis
2007
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells.
1990
Multiple Myeloma
2011 Standout
Resolution Phase of Inflammation: Novel Endogenous Anti-Inflammatory and Proresolving Lipid Mediators and Pathways
2006
Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003
2007
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
Leukotriene B 4 ‐ induced changes in vascular permeability are mediated by neutrophil release of heparin‐binding protein (HBP/CAP37/azurocidin)
2009
Flow-mediated endothelial mechanotransduction
1995 Standout
Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications
2001 Standout
Autocrine/Paracrine Mechanisms in Human Hematopoiesis
2001
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
2004
Works of R. Lerner being referenced
Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes
2005
Granulocyte‐macrophage colony‐stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial
2004
Platelet activating factor and leukotriene B4 induce hyperpolarisation of human endothelial cells but depolarization of neutrophils
1988
Corynebacterium Group JK in a Hematological Ward: Infections, Colonization and Environmental Contamination
1988
Rapid Adhesive Responses of Endothelial Cells and of Neutrophils Induced by Leukotriene B4 are Mediated by Leucocytic Adhesion Protein CD18
1990
An alloimmunized, thrombocytopenic patient successfully transfused with acid‐treated, random‐donor platelets
1991
Ceftazidime as Initial Therapy in Febrile Patients with Acute Leukemia during Induction Chemotherapy
1992
Leukotriene B4 induced hyperadhesiveness of endothelial cells for neutrophils
1990
Bone Marrow in Polycythemia Vera, Chronic Myelocytic Leukemia, and Myelofibrosis Has an Increased Vascularity
2000
Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias
1992
A Pilot Study of Piperacillin and Ciprofloxacin as Initial Therapy for Fever in Severely Neutropenic Leukemia Patients
1992
Lipoxin A4 induces hyperadhesiveness in human endothelial cells for neutrophils
1993
Signal transduction mechanisms for leukotriene B4 induced hyperadhesiveness of endothelial cells for neutrophils.
1994
Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma
1983
Development and characterization of essential fatty acid deficiency in human endothelial cells in culture.
1995